These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 832652)

  • 21. Pharmacokinetic and pharmacodynamic studies of procainamide given intermittently intravenously in patients with severe ventricular arrhytmias.
    Wierzchowiecki M; Jasiński K; Trojanowicz R; Ochotny R; Tomaszkiewicz T
    Cor Vasa; 1978; 20(3):176-83. PubMed ID: 688755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of "Polarizing" infusions on anthiarrhythmic effects of beta-blockers.
    Rossi P; Aralda D; Cernigliaro C; D'Aulerio M; Carcano G
    G Ital Cardiol; 1976; 6(4):620-7. PubMed ID: 976659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Oral administration of procainamide for ventricular arrhythmia. Plasma concentrations during use of tablets(Pronestyl) and a slow-release preparation (Porcainamide Durettes)].
    Bliddal J
    Ugeskr Laeger; 1976 Sep; 138(40):2425-33. PubMed ID: 968996
    [No Abstract]   [Full Text] [Related]  

  • 24. Blood levels of drugs used in the treatment of cardiac arrhythmias.
    Kalman SM
    Clin Toxicol; 1978 Dec; 13(5):567-85. PubMed ID: 373974
    [No Abstract]   [Full Text] [Related]  

  • 25. Antiarrhythmic prophylaxis in ambulatory patients with coronary heart disease.
    Koch-Weser J
    Arch Intern Med; 1972 May; 129(5):763-72. PubMed ID: 4554558
    [No Abstract]   [Full Text] [Related]  

  • 26. Letter: Time-dependent effect of oral procainamide in patients with exertional arrhythmias.
    Levy RH; Gey GO; Bruce RA
    J Pharm Sci; 1974 Dec; 63(12):1958-9. PubMed ID: 4449032
    [No Abstract]   [Full Text] [Related]  

  • 27. The clinical use of procainamide.
    Miller RR; Greenblatt DJ
    Am J Hosp Pharm; 1974 Sep; 31(9):889-91. PubMed ID: 4607729
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiarrhythmic drug effect assessed from ventricular arrhythmia reduction in the ambulatory electrocardiogram and treadmill test: comparison of propranolol, procainamide and quinidine.
    Winkle RA; Gradman AH; Fitzgerald JW
    Am J Cardiol; 1978 Sep; 42(3):473-80. PubMed ID: 685858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of Kö 1173, a new anticonvulsant agent on experimental cardiac arrhythmias.
    Allen JD; Ekue JM; Shanks RG; Zaidi SA
    Br J Pharmacol; 1972 Aug; 45(4):561-73. PubMed ID: 5085230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The treatment of ventricular rhythm disturbances.
    Somberg JC; Miura D; Keefe DL
    Am Heart J; 1986 Jun; 111(6):1162-76. PubMed ID: 2424297
    [No Abstract]   [Full Text] [Related]  

  • 31. [Interaction of phenytoin with propranolol, procainamide and digoxin].
    Halawa B
    Pol Tyg Lek; 1985 Jul; 40(28):790-3. PubMed ID: 4059101
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical cardiology. Use of anti-arrhythmic agents other than digitalis.
    Dreifus LS
    J Kans Med Soc; 1970 Jul; 71(7):276-8. PubMed ID: 4393787
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evaluation of the efficacy of anti-arrhythmia agents in hyperkinetic ventricular arrhythmia].
    Bracchetti D; Mantovani B; Naccarella F; Lombardi G; Palmieri M
    Boll Soc Ital Cardiol; 1980; Suppl():117-23. PubMed ID: 7349604
    [No Abstract]   [Full Text] [Related]  

  • 34. Procainamide acetylation and disposition in dialysis patients.
    Nattel S; Ogilvie RI; Kreeft J; Sitar DS; Graham DN; Rangno RE; Dufresne LR; Barre PE
    Clin Invest Med; 1979; 2(1):5-11. PubMed ID: 509808
    [No Abstract]   [Full Text] [Related]  

  • 35. Procaine amide against re-entrant ventricular arrhythmias. Lengthening R-V intervals of coupled ventricular premature depolarization as an insight into the mechanism of action of procaine amide.
    Giardina EG; Bigger JT
    Circulation; 1973 Nov; 48(5):959-70. PubMed ID: 4270892
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacodynamics of practolol in chronic renal failure.
    Eastwood JB; Curtis JR; Smith RB
    Br Med J; 1973 Nov; 4(5888):320-2. PubMed ID: 4758423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Quinidine interactions with propranolol, phenytoin, verapamil and procainamide].
    Halawa B
    Pol Tyg Lek; 1984 Jun; 39(24):823-6. PubMed ID: 6494041
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of experimental cardiac arrhythmias of a new anticonvulsant agent, Kö 1173, and its comparison with phenytoin and procainamide.
    Allen JD; Kofi JM; Shanks RG; Zaidi SA
    Br J Pharmacol; 1970 May; 39(1):183P-184P. PubMed ID: 4192640
    [No Abstract]   [Full Text] [Related]  

  • 39. Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapy.
    Rae AP; Sokoloff NM; Webb CR; Spielman SR; Greenspan AM; Horowitz LN
    J Am Coll Cardiol; 1985 Aug; 6(2):410-6. PubMed ID: 4019928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical use of diphenylhydantoin (dilantin) in the treatment and prevention of cardiac arrhythmias.
    Helfant RH; Seuffert GW; Patton RD; Stein E; Damato AN
    Am Heart J; 1969 Mar; 77(3):315-23. PubMed ID: 4179761
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.